• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD BHR RESURFACING FEMORAL HEAD 38MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD BHR RESURFACING FEMORAL HEAD 38MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 74121138
Device Problems Mechanical Problem (1384); Biocompatibility (2886); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Synovitis (2094); Ambulation Difficulties (2544); Metal Related Pathology (4530); Implant Pain (4561)
Event Date 10/28/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that a revision surgery was performed on the patient right hip on (b)(6) 2020.The revision surgery was performed due to chronic pain, fluid collection, and elevated chromium and cobalt levels from the mechanical failure of the right hip resurfacing arthroplasty, consistent with metal-on-metal wear.Among the intraoperative findings there was synovial fluid from the mechanical failure of the birmingham right hip resurfacing arthroplasty, resulting from metal-on-metal wear and adverse metal reaction.The patient outcome is unknown.
 
Manufacturer Narrative
It was reported that hip revision surgery was performed.As of today, the implanted devices, all of which were used in treatment, and additional information have been requested for this complaint but have not become available.As no device part and batch numbers were provided for investigation, a complaint history review, manufacturing record review and device labelling / ifu review could not be performed.If more information is received, this investigation will be reopened.A risk management review was performed.No additional risks were identified as result of the reported event and no further actions are required at this time.The available medical documents were reviewed.The revision operative report documents; ¿the patient has an extremely dysplastic and shrunken ileum secondary to radiation as a child for a wilms tumor.¿ elevated cobalt and chromium - cobalt level = 7.6 (no unit of measure provided)¿ a minimal amount of synovial fluid which was aspirated and sent for culture ¿ no infection was identified.¿ we encountered sclerotic bone behind the bhr stem.¿ the impact to the patient beyond the pain, the revision surgery, and the recovery cannot be determined.The clinical information provided, of the elevated metal ion levels and the pain, may be consistent with a reaction to metal debris.However, the source and the root cause cannot be determined with the available documentation.It cannot be concluded that the reported clinical findings are associated with the implant failure.It is unknown if the ¿sclerotic bone¿ was a result of the previous radiation or other undetermined causes.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint, and our investigation remains inconclusive.If the products or additional information become available in the future, this case will be reopened.No preventative or corrective action has been initiated as a result of this investigation.
 
Manufacturer Narrative
It was reported that right hip revision surgery was performed due to pain, limited ability to ambulate, elevated cobalt and chromium levels and synovial tissue inflammation.An mri revealed bhr system mechanical failure.The devices, used in treatment, were not returned for analysis.As no device part and batch numbers were provided for investigation, a full complaint history review or manufacturing record review could not be performed.If more information is received, this investigation will be reopened.A review of the historical complaints data was performed, using part numbers and the reported failure modes to evaluate patterns of repeated failures or defects in a timeframe prior 12 months to the complaint being reopened.No complaints were identified for either part in the year prior to the complaint being reopened.Complaint trends will continue to be monitoed via routine post market surveillance activities, however it should be noted that devices of this size are no longer sold.A risk management review was performed.No additional risks were identified as result of the reported event and no further actions are required at this time.A review of the current product ifu found adequate warnings and precautions in relation to the alleged failure modes.A review of historical corrective and preventive actions, preliminary risk assessment, health hazard evaluations, and field actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions are required.The available medical documentation was reviewed.In conclusion, the clinical root cause of the elevated metal ion levels and the pain cannot be determined with the available documentation.It cannot be concluded that the reported clinical findings are associated with the implant failure.It is unknown if the ¿sclerotic bone¿ was a result of the previous radiation or other undetermined causes.The impact to the patient beyond the pain, the revision surgery, and the recovery cannot be determined.Based on the information provided we cannot further investigate the complaint, our investigation remains inconclusive and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.If the products or additional information become available in the future, this case will be reopened.Based on this investigation the need for corrective and preventative action is not indicated.
 
Event Description
It was reported that, after undergoing right hip resurfacing (bhr) on, the patient developed chronic hip pain, limited ability to ambulate.Upon clinical evaluation, she was found to present elevated cobalt and chrome levels in blood and right hip synovial tissue inflammation.In addition, and mri revealed bhr system mechanical failure.These complications were treated by conducting a conversion to total hip arthroplasty on (b)(6) 2020, in which the femoral resurfacing head was explanted and the acetabular cup was retained.A birmingham dual mobility xlpe insert was placed along with a polarstem femoral stem and an oxinium femoral head.Patient¿s outcome is unknown.
 
Manufacturer Narrative
H10- additional information: a2- age at the time of event: a4- patient weight b6- relevant tests b7- other relevant history d4¬- catalog number, unique identifier (udi) # h11- corrected data.B1- adverse event and product problem b5- describe event or problem d1- brand name e1- initial reporter name and address g2- report source h6- evaluation codes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BHR RESURFACING FEMORAL HEAD 38MM
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key11167385
MDR Text Key226772516
Report Number3005975929-2021-00004
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010502766
UDI-Public3596010502766
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional,Company Representative
Reporter Occupation Other
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date 07/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/13/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number74121138
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received07/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-2745-2015
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
Patient SexFemale
Patient Weight70 KG
-
-